Executive Profile

Samuel D. Colella MBA Managing Director, Versant Ventures, Inc.

Age	Total Calculated Compensation	This person is connected to 7 Board Members in 7 different organizations across 18 different industries. See Board Relationships
72	--

Background

Mr. Samuel D. Colella, Sam, MBA serves as Managing Director of Versant Ventures, Inc. Mr. Colella Co-founded in 1999 with six other Managing Directors and specializes in life sciences investing at it. Mr. Colella has been a venture capital investor since 1984. He has had 20 years of successful operating experience in the high technology industry and more than 25 years of investing experience in the healthcare sector and is recognized for his leadership in life science ... investing. Mr. Colella has held senior level positions in a diverse array of businesses, including president of Spectra-Physics, the world’s leading laser supplier, and senior manager of the Technical Products Division of Corning Glass. He served as a Strategic Advisor at The Column Group. He joined Institutional Venture Partners in 1984 and as a General Partner launched its Life Science Group in 1985. With vita Pharmaceuticals Inc. He has been the Chairman of Fluidigm Corporation since July 2000. He serves as the Chairman of Thermage. He served as the Chairman of Takeda California, Inc. He has been a Director of Integrated Medical Resources Inc. since December 1995 and DoubleTwist Inc. since February 1997. He serves as a Director of Onyx Pharmaceuticals Inc. He serves as a Director of BenefitPoint Inc., Collabrys, PPD Biomarker Discovery Sciences, LLC, Rennovia, Inc., 5AM, Euro Ventures, Inc., Kinestral Technologies Inc., Quanticel Pharmaceuticals, Inc., Flexion, Biosys Inc., Vivus Inc., QC Pharma, Veracyte, Inc., Genta Inc. and Pharmacopeia. He served as a Director of Five Prime Therapeutics, Inc. and Alavita Pharmaceuticals Inc. He has been a Director at Nanoplex Technologies Inc since May 9, 2005 and Genomic Health Inc. since January 2001. Mr. Colella served as a Director of Symyx Technologies Inc. from August 1997 to June 2007. Mr. Colella served as a Director at Imagyn Medical Inc. since January 1990. He served on the Board of Alexza Pharmaceuticals from September 2002 to June 2012, Tularik, Thermowave, Jazz Pharmaceuticals, IVAC Holdings, Imagyn, Genpharm International, Endosonics, CV Therapeutics, Biasys, Aviron, Arthrocare, Athena Neurosciences, Argonaut Technologies. Over the course of his venture career, in addition to building two major venture capital firms, Mr. Colella has served as a Director on over 30 health care companies. His professional affiliations include a term as the Chairman at the Stanford Council on Interdisciplinary Biosciences. In 2010, he received the Lifetime Achievement Award from the National Venture Capital Association. In 2001, Mr. Colella was awarded with the Distinguished Athletic Letterman from the University of Pittsburgh. In 2002, he was inducted into the University of Pittsburgh’s Legacy Laureate Society. In 2005, Mr. Colella received the American Liver Foundation’s Salute to Excellence Award. He is a Richard H. Holton Teaching Fellow at the Haas School of Business, U.C. Berkeley. Mr. Colella received an M.B.A. from Stanford University and a B.A. and B.S. in Business and Engineering from the University of Pittsburgh.

Corporate Headquarters 3000 Sand Hill Road Menlo Park, California 94025 United States Phone: 650-233-7877 Fax: 650-854-9513 Board Members Memberships Prior Argonaut Technologies, Inc. Former Director BenefitPoint, Inc. Former Director Genta Incorporated Director PPD Biomarker Discovery Sciences, LLC Chairman of the Board Takeda California, Inc. Director 5AM Ventures Former Director Five Prime Therapeutics, Inc. Former Director Oxonica Inc. Director Veracyte, Inc. Director Flexion Therapeutics, Inc. Director Rennovia, Inc. Director Alavita Pharmaceuticals Inc. Director Euro Ventures, Inc. Director Quanticel Pharmaceuticals, Inc. Director Kinestral Technologies Inc. 1990-N/A Former Director Imagyn Medical, Inc. 1995-N/A Former Director Integrated Medical Resources, Inc. 1997-N/A Former Director DoubleTwist, Inc. 1997-2007 Former Director, Chairman of Compensation Committee and Member of Governance Committee Symyx Technologies Inc. 1997-2007 Former Chairman, Chairman of Compensation Committee, Member of Audit Committee and Member of Nominating & Governance Committee Solta Medical, Inc. 2000-Present Chairman of the Board, Chairman of Compensation Committee and Chairman of Nominating & Corporate Governance Committee Fluidigm Corporation 2001-Present Independent Director and Member of Compensation Committee Genomic Health Inc. 2002-2012 Former Director, Chairman of Compensation Committee, Member of Nominating & Corporate Governance Committee and Member of Finance Committee Alexza Pharmaceuticals Inc. 2004-2012 Former Member of the Board of Directors, Member of Nominating & Corporate Governance Committee and Member of Compensation Committee Jazz Pharmaceuticals Public Limited Company Education MBA Stanford University BA University of Pittsburgh BS University of Pittsburgh Other Affiliations Institutional Venture Partners Argonaut Technologies, Inc. BenefitPoint, Inc. Genta Incorporated Imagyn Medical, Inc. DoubleTwist, Inc. PPD Biomarker Discovery Sciences, LLC Symyx Technologies Inc. Solta Medical, Inc. Takeda California, Inc. Stanford University Integrated Medical Resources, Inc. Spectra-Physics, Inc. Fluidigm Corporation Genomic Health Inc. 5AM Ventures Five Prime Therapeutics, Inc. Versant Venture Capital II, L.P. University of Pittsburgh Stanford Graduate School of Business National Venture Capital Association Jazz Pharmaceuticals Public Limited Company Western Association of Venture Capitalists American Entrepreneurs for Economic Growth Oxonica Inc. Versant Venture Capital III, L.P. Alexza Pharmaceuticals Inc. The Column Group LLC Veracyte, Inc. Versant Venture Capital IV, L.P. Flexion Therapeutics, Inc. Rennovia, Inc. Alavita Pharmaceuticals Inc. Euro Ventures, Inc. Quanticel Pharmaceuticals, Inc. Kinestral Technologies Inc.

Annual Compensation There is no Annual Compensation data available. Stocks Options There is no Stock Options data available. Total Compensation There is no Total Compensation data available.

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.